Search Results

Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the initiation of the first US-based clinical study to collect real-world data to compare workflows between traditional stress tests and the CADScor System.

The Board of Acarix AB (publ) announces the immediate appointment of Aamir Mahmood as its new CEO, effective February 1.

Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointment of three new advisors to its team.

Acarix is pleased to announce the results from a 2024 American College of Cardiology poster presentation by Suzanne Baron, MD, MSc, Director of Interventional Cardiology Research, Massachusetts General Hospital and Faculty at The Baim Institute for Clinical Research, to assess the cost-utility of the CADScor System for the evaluation of coronary artery disease in a low-risk patient population presenting to the Emergency Department with chest pain.

The results from the extensive study are expected to be available early 2020.